lisdexamfetamine dimesylate
NDC 47781-564, lisdexamfetamine dimesylate, capsule, from Alvogen Inc..
- Product NDC
- 47781-564
- Status
- Listed
- Labeler
- Alvogen Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214547
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/47781-564 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE30 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47781-564-01 | 47781056401 | 100 CAPSULE in 1 BOTTLE (47781-564-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7f2dd6ee-3363-c87c-9693-ed838942556cNADAC price for package 47781056401
GET /v1/drugs/nadac/47781056401
Use it
Look up 47781-564 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47781-564 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47781-564. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.